Maternal inulin alleviates high-fat diet-induced lipid disorder in offspring by epigenetically modulating hypothalamus feeding circuit-related genes.
Qian ZhangXinhua XiaoJia ZhengMing LiMiao YuFan PingTong WangPublished in: Food & function (2023)
Increasing evidence supports the existence of fetal-originated adult diseases. Recent research indicates that the intrauterine environment affects the fetal hypothalamic energy intake center. Inulin is a probiotic that can moderate metabolic disorders, but whether maternal inulin intervention confers long-term metabolic benefits to lipid metabolism in offspring in their adult lives and the mechanism involved are unknown. Here, we used a maternal overnutrition model that was induced by excess energy intake before and during pregnancy and lactation and maternal inulin intervention was performed during pregnancy and lactation. The hypothalamic genome methylation in offspring was analyzed using a methylation array. The results showed that maternal inulin treatment modified the maternal high-fat diet (HFD)-induced increases in body weight, adipose tissue weight, and serum insulin and leptin levels and decreases in serum adiponectin levels. Maternal inulin intervention regulated the impairments in hypothalamic leptin resistance, induced the methylation of Socs3 , Npy , and Il6 , and inhibited the methylation of Lepr in the hypothalamus of offspring. In conclusion, maternal inulin intervention modifies offspring lipid metabolism, and the underlying mechanism involves the methylation of genes in the hypothalamus feeding circuit.
Keyphrases
- high fat diet
- adipose tissue
- birth weight
- insulin resistance
- pregnancy outcomes
- genome wide
- randomized controlled trial
- weight gain
- dna methylation
- body weight
- type diabetes
- gestational age
- metabolic syndrome
- skeletal muscle
- pregnant women
- body mass index
- physical activity
- high throughput
- high glucose
- signaling pathway
- transcription factor
- mouse model
- high resolution
- dairy cows
- long noncoding rna
- glycemic control
- combination therapy
- genome wide analysis